Results 121 to 130 of about 20,009 (190)

Structural insights into VLDLR recognition by western equine encephalitis virus. [PDF]

Nat Commun
Liang S, Xu Z, Liu X, Yang Y, Zhao L, Hu C, Hou J, Wei Z, Zhang Y, Li D, Yang J, Zhang J, Bi J, Wang Y, Lou Z.   +14 more
europepmc   +1 more source

Subxiphoid epicardial approach for catheter ablation of refractory perimitral atrial flutter: a case series. [PDF]

Eur Heart J Case Rep
Ollitrault P, Champ-Rigot L, Descamps R, Pottier V, Ferchaud V, Font J, Pellissier A, Milliez PU.   +7 more
europepmc   +1 more source

Does the Chimerization Process Affect the Immunochemical Properties of WNV-Neutralizing Antibody 900? [PDF]

Int J Mol Sci
Isaeva AA, Nesmeyanova VS, Shanshin DV, Ushkalenko ND, Volosnikova EA, Esina TI, Protopopova EV, Svyatchenko VA, Loktev VB, Olkin SE, Danilenko ED, Kazachinskaia EI, Shcherbakov DN.   +12 more
europepmc   +1 more source

Low density lipoprotein receptor-related protein 8: a critical receptor for tick-borne encephalitis virus entry. [PDF]

Signal Transduct Target Ther
Jiao P, Du L, Zeng Y.
europepmc   +1 more source

Inhibition of dengue virus type 2 by hypericin mediated through viral envelope protein interaction. [PDF]

Virol J
Qi L, Tang M, Liu L, Cheng J, Xiao Q, Qiu J, Wu J.   +6 more
europepmc   +1 more source

A two-component cocktail of engineered DIII nanoparticles elicits broadly neutralizing antibody responses against dengue virus in mice. [PDF]

iScience
Mariano MC, Jung HS, Vergnolle O, Haskell K, Evanson LR, Quevedo G, Frei JC, Tong K, Thackray LB, Diamond MS, Lai JR.   +10 more
europepmc   +1 more source

Profiling Immune-Independent Response to Immune Checkpoint Inhibitors on Stem Cell-Derived Cardiomyocytes, Organoids, and Mouse Models. [PDF]

Circulation
Thomas D, Manhas A, Liu Y, Venkateshappa R, Belbachir N, Zhao SR, Juguilon C, Chen IY, Moslehi J, Sayed N, Wu JC.   +10 more
europepmc   +1 more source

Serum profiling of uPA, PAI-1, and suPAR in systemic sclerosis: a preliminary study on analytical aspects and associations with microvascular and fibrotic manifestations. [PDF]

Front Immunol
Napolitano F, Mormile I, Mignogna G, de Paulis A, Rossi FW, Montuori N.   +5 more
europepmc   +1 more source

Peptides developed against receptor binding sites of the E glycoprotein neutralize tick-borne encephalitis virus. [PDF]

Sci Rep
Petroušková P, Bhide K, Mochnáčová E, Kulkarni A, Jozefiaková J, Tkáčová Z, Maľarik T, Kucková K, Talpašová L, Víglaský J, Kevély Á, Koči K, Nováková E, Koči J, Bhide M.   +14 more
europepmc   +1 more source

Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine. [PDF]

Cell Rep
Grinyo-Escuer A, Reddy S, Chenine AL, Whitbeck JC, Jacobsen S, Sheetz A, Doolan K, Norden DM, Frey N, Holtsberg FW, Aman MJ, Fink K, Diamond MS, Schieffelin JS, Crowe JE, Davidson E, Doranz BJ.   +16 more
europepmc   +1 more source